...
首页> 外文期刊>Journal of clinical laboratory analysis. >Time-resolved fluorescent immunoassay-based combined detection of procalcitonin, C-reactive protein, heparin binding protein, and serum amyloid A1 to improve the diagnostic accuracy of early infection
【24h】

Time-resolved fluorescent immunoassay-based combined detection of procalcitonin, C-reactive protein, heparin binding protein, and serum amyloid A1 to improve the diagnostic accuracy of early infection

机译:基于时间分辨的荧光免疫测定的转移性荧光素,C反应蛋白,肝素结合蛋白和血清淀粉样蛋白A1,提高早期感染的诊断准确性

获取原文
获取原文并翻译 | 示例
           

摘要

Background Serological tests are indispensable in the diagnosis of early infection. At present, only procalcitonin (PCT) and C-reactive protein (CRP) are commonly used in clinical practice. Recently, serum amyloid A1 (SAA1) and heparin binding protein (HBP) have been shown to be new biomarkers, because SAA1 is highly sensitive and specific for viral infections, and HBP is predictive for septic shock. In this study, PCT, CRP, HBP, and SAA1 were detected in different combinations to improve the diagnostic accuracy of early infection using the biotin-avidin amplifying system-based time-resolved fluorescent immunoassay (BA-TRFIA). Methods A time-resolved fluorescent immunoassay for PCT, CRP, HBP, and SAA1 was developed and then tested in a clinical setting. All experiments were carried out using the DR6608 time-resolved fluorescent immunoassay analyzer. Results The cutoff values of PCT, CRP, HBP, and SAA1 were 0.05 mu g/L, 5.59 mg/L, 3.83 mu g/L, and 1.56 mg/L, respectively. The area under the ROC curve (AUC) showed that PCT SAA1 CRP HBP 0.8. A methodological comparison of the results showed that a combination of the four biomarkers had the highest accuracy for the diagnosis of infectious diseases. Conclusion The time-resolved fluorescent immunoassay-based combined detection of PCT, CRP, HBP, and SAA1 was shown to significantly improve the diagnostic accuracy of early infection. Thus, our results indicate that combined detection based on BA-TRFIA may represent a promising strategy in the clinical diagnosis of infection.
机译:背景技术血清学试验在早期感染的诊断中是必不可少的。目前,仅在临床实践中仅使用ProCalcitonin(PCT)和C反应蛋白(CRP)。最近,已显示血清淀粉样蛋白A1(SAA1)和肝素结合蛋白(HBP)是新的生物标志物,因为SAA1对病毒感染具有高敏感性并且特异性,HBP对脓乳酸休克预测性。在该研究中,以不同的组合检测PCT,CRP,HBP和SAA1,以改善使用基于生物素 - 抗生物素蛋白扩增系统的时间分辨荧光免疫测定(BA-TRFIA)的早期感染的诊断准确性。方法开发PCT,CRP,HBP和SAA1的时间分辨荧光免疫测定,然后在临床环境中进行测试。使用DR6608时间分离的荧光免疫测定分析仪进行所有实验。结果PCT,CRP,HBP和SAA1的截止值分别为0.05μg/ L,5.59mg / L,3.83μg/ L和1.56mg / L. ROC曲线(AUC)下的区域显示PCT> SAA1> CRP& HBP& 0.8。结果表明,结果表明,四种生物标志物的组合具有最高的感染性疾病的准确性。结论表明,PCT,CRP,HBP和SAA1的基于PCT,CRP,HBP和SAA1的基于时间的荧光免疫测定的组合检测显着提高了早期感染的诊断准确性。因此,我们的结果表明,基于BA-TRFIA的组合检测可以代表感染临床诊断中有希望的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号